Specifically, monoclonal antibody mAb47 has shown efficacy in suppressing tumor angiogenesis and inhibiting the growth of both EphB4-positive and EphB4-negative tumors, suggesting its impact on the tumor microenvironment [160, 161]. The gene discussed is EPHB4; the disease is neoplasm.